The Prognostic Impact of Estimated Creatinine Clearance by Bioelectrical Impedance Analysis in Heart Failure: Comparison of Different eGFR Formulas
- PMID: 34680423
- PMCID: PMC8533548
- DOI: 10.3390/biomedicines9101307
The Prognostic Impact of Estimated Creatinine Clearance by Bioelectrical Impedance Analysis in Heart Failure: Comparison of Different eGFR Formulas
Abstract
The estimation of glomerular filtration rate (eGFR) provides prognostic information in patients with heart failure (HF). Bioelectrical impedance analysis may calculate eGFR (Donadio formula). The aim of this study was to evaluate the impact of the Donadio formula in predicting all-cause mortality in patients with HF as compared to Cockroft-Gault, MDRD-4 (Modification of Diet in renal Disease Study), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formulas. Four-hundred thirty-six subjects with HF (52% men; mean age 75 ± 11 years; 42% acute HF) were enrolled. Ninety-two patients (21%) died during the follow-up (median 463 days, IQR 287-669). The area under the receiver operator characteristic curve for eGFR, as estimated by Cockroft-Gault formula (AUC = 0.75), was significantly higher than those derived from Donadio (AUC = 0.72), MDRD-4 (AUC = 0.68), and CKD-EPI (AUC = 0.71) formulas. At multivariate analysis, all eGFR formulas were independent predictors of death; 1 mL/min/1.73 m2 increase in eGFR-as measured by Cockroft-Gault, Donadio, MDRD-4, and CKD-EPI formulas-provided a 2.6%, 1.5%, 1.2%, and 1.6% increase, respectively, in mortality rate. Conclusions. eGFR, as calculated with the Donadio formula, was an independent predictor of mortality in patients with HF as well as the measurements derived from MDRD4 and CKD-EPI formulas, but less accurate than Cockroft-Gault.
Keywords: BIA; BNP; acute heart failure; chronic heart failure; clearance creatinine; prognosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


References
-
- Mullens W., Damman K., Testani J.M., Martens P., Mueller C., Lassus J., Tang W.W., Skouri H., Verbrugge F.H., Orso F., et al. Evaluation of kidney function throughout the heart failure trajectory–A position statement from the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2020;22:584–603. doi: 10.1002/ejhf.1697. - DOI - PubMed
-
- Grande D., Gioia M.I., Terlizzese P., Iacoviello M. Heart failure and kidney disease. Adv. Exp. Med. Biol. 2018;1067:219–238. - PubMed
-
- Kang J., Park J.J., Cho Y., Oh I., Park H., Lee S.E., Kim M., Cho H., Lee H., Choi J.O., et al. Predictors and prognostic value of worsening renal function during admission in HFpEF Versus HFrEF: Data from the KorAHF (Korean Acute Heart Failure) registry. J. Am. Heart Assoc. 2018;7:e007910. doi: 10.1161/JAHA.117.007910. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources